Related Experiment Video

Updated: Jun 1, 2026

Protocol for the Differentiation of Human Induced Pluripotent Stem Cells into Mixed Cultures of Neurons and Glia for Neurotoxicity Testing
09:02

Protocol for the Differentiation of Human Induced Pluripotent Stem Cells into Mixed Cultures of Neurons and Glia for Neurotoxicity Testing

Published on: June 9, 2017

Bilirubin production and the risk of bilirubin neurotoxicity

David K Stevenson1, Hendrik J Vreman, Ronald J Wong

  • 1Department of Pediatrics, Division of Neonatal and Developmental Medicine, Stanford University School of Medicine, Stanford, CA 94305-5208, USA. dstevenson@stanford.edu

Seminars in Perinatology
|June 7, 2011
PubMed

Insights

Neonatal jaundice, or high bilirubin levels, can cause brain damage in newborns. Identifying infants with increased bilirubin production, like from hemolysis, is key to preventing neurotoxicity.

Area of Science:

  • Neonatology
  • Pediatric Neurology
  • Biochemistry

Background:

  • Neonatal jaundice is common, characterized by elevated circulating bilirubin.
  • Excessive bilirubin (hyperbilirubinemia) can lead to bilirubin neurotoxicity.
  • Newborn jaundice stems from increased bilirubin production or impaired conjugation.

Purpose of the Study:

  • To assess infant risk for bilirubin neurotoxicity based on plasma bilirubin levels and age in hours.
  • To highlight the importance of identifying infants with increased bilirubin production.
  • To emphasize the need for preventive strategies and noninvasive treatments for neonatal jaundice.

Main Methods:

  • Utilizing plasma bilirubin levels to assess neurotoxicity risk.
  • Considering infant age in hours for risk stratification.
  • Evaluating the role of hemolysis in increasing bilirubin production.

Main Results:

  • Infants with impaired conjugation are at risk, especially those with increased bilirubin production.
  • Hemolysis is a significant factor contributing to elevated bilirubin production.
  • Plasma bilirubin levels correlate with the risk of neurotoxicity relative to infant age.

Conclusions:

  • Infants with increased bilirubin production rates are at the highest risk for neurotoxicity.
  • Preventive strategies and noninvasive technologies are crucial for reducing bilirubin-induced neurologic dysfunction.
  • Early identification of infants with high bilirubin production is paramount for timely intervention.

More Related Videos

Measurement of Heme Synthesis Levels in Mammalian Cells09:43

Measurement of Heme Synthesis Levels in Mammalian Cells

Published on: July 9, 2015

A Neuronal and Astrocyte Co-Culture Assay for High Content Analysis of Neurotoxicity15:04

A Neuronal and Astrocyte Co-Culture Assay for High Content Analysis of Neurotoxicity

Published on: May 5, 2009

Related Concept Videos

Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...